TY - JOUR
T1 - Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration
AU - ARTFL and LEFFTDS consortia
AU - Olney, Nicholas T.
AU - Ong, Elise
AU - Goh, Sheng Yang M.
AU - Bajorek, Lynn
AU - Dever, Reilly
AU - Staffaroni, Adam M.
AU - Cobigo, Yann
AU - Bock, Meredith
AU - Chiang, Kevin
AU - Ljubenkov, Peter
AU - Kornak, John
AU - Heuer, Hilary W.
AU - Wang, Ping
AU - Rascovsky, Katya
AU - Wolf, Amelia
AU - Appleby, Brian
AU - Bove, Jessica
AU - Bordelon, Yvette
AU - Brannelly, Patrick
AU - Brushaber, Danielle
AU - Caso, Christine
AU - Coppola, Giovanni
AU - Dickerson, Bradford C.
AU - Dickinson, Susan
AU - Domoto-Reilly, Kimiko
AU - Faber, Kelly
AU - Ferrall, Jessica
AU - Fields, Julie
AU - Fishman, Ann
AU - Fong, Jamie
AU - Foroud, Tatiana
AU - Forsberg, Leah K.
AU - Gearhart, Debra J.
AU - Ghazanfari, Behnaz
AU - Ghoshal, Nupur
AU - Goldman, Jill
AU - Graff-Radford, Jonathan
AU - Graff-Radford, Neill R.
AU - Grant, Ian
AU - Grossman, Murray
AU - Haley, Dana
AU - Hsiung, Gingyuek
AU - Huey, Edward D.
AU - Irwin, David J.
AU - Jones, David T.
AU - Kantarci, Kejal
AU - Karydas, Anna M.
AU - Kaufer, Daniel
AU - Kerwin, Diana
AU - Knopman, David S.
N1 - Funding Information:
The authors extend their appreciation to Drs. John Hsiao and Dallas Anderson from the National Institute on Aging, Drs. Marg Sutherland and Codrin Lungu from the National Institute of Neurological Disorders and Stroke, the staff of all centers, and particularly to our patients and their families for their participation in this protocol. This work is supported by the National Institutes of Health (grants AG045390 [LEFFTDS], NS092089 [ARTFL], AG032306 , AG021886 , AG016976 , AG019724 , AG038791 , AG056749 and AG045333 ) and the Larry L. Hillblom Foundation (2018-A-025-FEL). Samples from the National Centralized Repository for Alzheimer Disease and Related Dementias (NCRAD), which receives government support under a cooperative agreement grant (AG21886) awarded by the National Institute on Aging (NIA), were used in this study. Research in context 1. Systematic review: The authors reviewed the literature using traditional sources (e.g., PubMed) and meeting abstracts and presentations. 2. Interpretation: Our results indicate that imaging abnormalities can serve as early indicators of oncoming functional deterioration in frontotemporal lobar degeneration. However, the specific brain regions and clinical abnormalities that herald the onset of functional change likely vary across individuals. 3. Future directions: The study lays the groundwork for future longitudinal studies to determine the timing between imaging and clinical changes and to define the best combination of imaging abnormalities and clinical measures for predicting functional changes.
Funding Information:
The authors extend their appreciation to Drs. John Hsiao and Dallas Anderson from the National Institute on Aging, Drs. Marg Sutherland and Codrin Lungu from the National Institute of Neurological Disorders and Stroke, the staff of all centers, and particularly to our patients and their families for their participation in this protocol. This work is supported by the National Institutes of Health (grants AG045390 [LEFFTDS], NS092089 [ARTFL], AG032306, AG021886, AG016976, AG019724, AG038791, AG056749 and AG045333) and the Larry L. Hillblom Foundation (2018-A-025-FEL). Samples from the National Centralized Repository for Alzheimer Disease and Related Dementias (NCRAD), which receives government support under a cooperative agreement grant (AG21886) awarded by the National Institute on Aging (NIA), were used in this study.
Publisher Copyright:
© 2019 The Authors. Alzheimer's & Dementia published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Introduction: The Advancing Research and Treatment in Frontotemporal Lobar Degeneration and Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects longitudinal studies were designed to describe the natural history of familial-frontotemporal lobar degeneration due to autosomal dominant mutations. Methods: We examined cognitive performance, behavioral ratings, and brain volumes from the first time point in 320 MAPT, GRN, and C9orf72 family members, including 102 non–mutation carriers, 103 asymptomatic carriers, 43 mildly/questionably symptomatic carriers, and 72 carriers with dementia. Results: Asymptomatic carriers showed similar scores on all clinical measures compared with noncarriers but reduced frontal and temporal volumes. Those with mild/questionable impairment showed decreased verbal recall, fluency, and Trail Making Test performance and impaired mood and self-monitoring. Dementia was associated with impairment in all measures. All MAPT carriers with dementia showed temporal atrophy, but otherwise, there was no single cognitive test or brain region that was abnormal in all subjects. Discussion: Imaging changes appear to precede clinical changes in familial-frontotemporal lobar degeneration, but specific early clinical and imaging changes vary across individuals.
AB - Introduction: The Advancing Research and Treatment in Frontotemporal Lobar Degeneration and Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects longitudinal studies were designed to describe the natural history of familial-frontotemporal lobar degeneration due to autosomal dominant mutations. Methods: We examined cognitive performance, behavioral ratings, and brain volumes from the first time point in 320 MAPT, GRN, and C9orf72 family members, including 102 non–mutation carriers, 103 asymptomatic carriers, 43 mildly/questionably symptomatic carriers, and 72 carriers with dementia. Results: Asymptomatic carriers showed similar scores on all clinical measures compared with noncarriers but reduced frontal and temporal volumes. Those with mild/questionable impairment showed decreased verbal recall, fluency, and Trail Making Test performance and impaired mood and self-monitoring. Dementia was associated with impairment in all measures. All MAPT carriers with dementia showed temporal atrophy, but otherwise, there was no single cognitive test or brain region that was abnormal in all subjects. Discussion: Imaging changes appear to precede clinical changes in familial-frontotemporal lobar degeneration, but specific early clinical and imaging changes vary across individuals.
KW - C9ORF72
KW - Familial
KW - Frontotemporal lobar degeneration
KW - GRN
KW - Genetic
KW - MAPT
UR - http://www.scopus.com/inward/record.url?scp=85075806070&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075806070&partnerID=8YFLogxK
U2 - 10.1016/j.jalz.2019.08.196
DO - 10.1016/j.jalz.2019.08.196
M3 - Article
C2 - 31784375
AN - SCOPUS:85075806070
SN - 1552-5260
VL - 16
SP - 49
EP - 59
JO - Alzheimer's and Dementia
JF - Alzheimer's and Dementia
IS - 1
ER -